PHRM845 Exam 4 Flashcards

Pathophysiology of anxiety and sleep disorders (63 cards)

1
Q

What is a sedative?

A

Calms anxiety, decreases excitement and activity, does not produce drowsiness, or impair performance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is an anxiolytic?

A

Antianxiety, relieves anxiety without sleep or sedation (not all anxiolytics are sedatives)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a hypnotic?

A

Induces sleep, implies restful, refreshing sleep, not “hypnotized!”, natural sleep (medial use term: sleeping-inducing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a narcotic?

A

Actually means “sleep producing”, now refers to opioids or illegal drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the reticular formation and where is it located?

A

-An intricate system composed of loosely clustered neurons in what is otherwise white matter
-The reticular formation extends through the central core of the medulla oblongata, pons, and midbrain.
-It is very complex; contains dopamine, adrenergic, serotonergic, and cholinergic neurons
-Regulates sleep-wake transitions and synchronization of EEG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stages of sleep

A

-Wakefulness
-Non-rapid eye movement (NREM) slow-wave sleep
-Rapid eye movement (REM) sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NREM sleep stages

A

Stage 1 (dozing)
Stage 2 (unequivocal sleep)
Stage 3 (voltage increase, frequency decrease)
Stage 4 (delta waves)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

EEG for REM sleep is similar to EEG when ___

A

Awake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sleep deprivation means a decrease in time in ___

A

Total Sleep
Delta Sleep
REM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Factors that regulate sleep

A

-Age: Decreases with age due to changes in activity of reticular formation
-Sleep History: Rebound of REM sleep
-Drug Ingestion: Acute and withdrawal produce rebound effects
-Circadian Rhythms: “Normal sleep cycle”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How long is an Ultradian Rhythm?

A

90 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Biological regulators of sleep

A

Neurotransmitters (almost all):
-Catecholamines (e.g., epinephrine, norepinephrine, and dopamine)
-Serotonin (5HT)
-Histamine
-Acetylcholine (ACh)
-Adenosine
-GABA (main target for current medications)
Neuromodulators:
-Growth Hormone (GH)
-Prolactin
-Cortisol
-Melatonin — “hormone of darkness”
-Endogenous Peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What neurotransmitter is the main target for current medications?

A

GABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is GABA?

A

Major inhibitory signal that quiets the brain down.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Explain impact of GABA in seizures and anxiety

A

Seizure-too much excitability (not enough GABA)
Anxiety-want to quiet excitatory neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

With GABA-A receptors, we want more ___ influx.

A

Cl-; chloride channel causes more negative charge and membrane becomes hyperpolarized making it harder to activate an action potential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do benzodiazepines bind to GABA-A receptor?

A

They bind at an allosteric binding site to allow more Cl- to enter.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

GABA-A receptor/chloride ion channel complex is a target for

A

Sedative-hypnotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Most common CNS GABA-A receptors

A

2a1, 2b2, 1g2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Orthosteric and allosteric sites on GABA-A receptor

A

Orthosteric site: GABA (a1 and b2)
Allosteric Sites- benzodiazepine (BZD) site (a1 and g2)
-Barbiturate
-Ethanol
-Glucocorticoid
-?
Channel pore (picrotoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Ligands acting at the BZD Receptor

A

-Benzodiazepines: Facilitate GABA action (e.g., a1-5), increase frequency, require intact GABA system (internal safety system)
-Non-Benzodiazepines (Z-Hypnotics): zolpidem (Ambien®), zaleplon (Sonata®), eszopiclone (LunestaTM) – BZ1 receptors of a1
-BZD Antagonists: flumazenil (Romazicon®), overdose treatment
-Inverse BZD Agonists: B carbolines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Benzodiazepines are (very/not very) specific. They are also (addictive/not addictive).

A

Not very specific
Addictive because it binds so many different targets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Z-hypnotics have (more/less) side effects because binding is very (specific/non-specific).

A

Less
specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Modulation of the GABA-A receptor
a. BZD
b. Barbiturates
c. Alcohol
d. GABA channel blockers
e. Etomidate and propofol
f. Neurosteroids

A

BZDs: Increase frequency of channel opening,
Barbiturtates (Bbt): Increase duration of channel opening, and direct effects on GABAA (high doses)

Alcohol: Enhances actions of GABA at GABAA receptor

GABA channel blockers: picrotoxin

Etomidate and Propofol (Diprovan; aka “milk of amnesia”): b2 and b3 subunit containing receptors

Neurosteroids (e.g., progesterone and deoxycortisone) for treating depression, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Importance of GABA channel blocker: Picrotoxin
Toxic, so don't use as a drug. Directly blocks ion conduction pathway,
26
Structure Activity relationships of Benzodiazepines
1 Position alkylation  source of active metabolites **Annealating the 1-2 bond with an “electron rich” ring (triazole or imidazole) yields high affinity and decreased half-life
27
Half-life of diazepam
Long
28
Use of Chlordiazepoxide (Librium®)
1st benzodiazepine, used as an anxiolytic and for alcohol withdrawal, accumulation of metabolites
29
Use of Diazepam (Valium®)
Prototypical benzodiazepine, used as an anxiolytic, for alcohol withdrawal, and for treatment of convulsive disorders (seizures), accumulation of metabolites
30
Use of Flurazepam (Dalmane®)
Used as a hypnotic, accumulation of metabolites
31
Use of Clorazepate (Tranxene®)
Used as an anxiolytic, for alcohol withdrawal, and for treatment of convulsive disorders, accumulation of metabolites
32
Use of Quazepam (Doral®)
Used as a hypnotic, accumulation of metabolites (good or bad for helping sleeping?)
33
Use of Prazepam (Currently unavailable in the US)
Used as an anxiolytic
34
Meds with slow elimination rates: all have active metabolites
Chlordiazepoxide (Librium®) Diazepam (Valium®) Flurazepam (Dalmane®) Clorazepate (Tranxene®) Quazepam (Doral®) Prazepam
35
Meds with intermediate elimination rates
Alprazolam Lorazepam Clonazepam Oxazepam Temazepam
36
Use of Alprazolam (Xanax®)
Withdrawal symptoms can present if abrupt discontinuation occurs, used as an anxiolytic and anesthetic
37
Use of Lorazepam (Ativan®)
Used as an anxiolytic and as a hypnotic
38
Use of Clonazepam (Klonopin®)
Tolerance may develop with prolonged use, used as an anticonvulsant
39
Use of Oxazepam (Serax®)
Used as an anxiolytic and for alcohol withdrawal
40
Use of Temazepam (Restoril®)
Used as a short-term hypnotic
41
Meds with rapid elimination rates
Midazolam and Triazolam
42
Use of Midazolam (Versed)
Rapid anesthesia
43
Importance of rapid elimination rates
Get in fast-->do job-->get out **Good for seizures
44
Benzodiazepines usage
Slow Elimination -Accumulation -Active Metabolites -Drowsiness and Sedation -Useful in patients who “wake up” Intermediate to Rapid Elimination -Preferable in patients with hepatic problems -Preferable in elderly patients -Drugs that alter liver enzymes -Rapid tolerance -Rebound Insomnia
45
Which meds should we be careful with in elderly patients and why?
Benzodiazepines Increase risk of falls, mobility, driving, and increase cognitive issues.
46
General considerations for benzodiazepines
-Readily absorbed (can delayed by food) -have active metabolites or are converted to active forms -Increased lipid solubility will increase speed of delivery to brain -Redistribution to highly perfused tissue may decrease duration of action -Cross placental barrier and are detected in breast milk -Extensive protein binding, but not clinically significant
47
Are barbituates or benzodiazepines more dangerous?
Barbituates; as you increase the dose, you just keep increasing the side effects -If you keep increasing the dose, it can lead to sedation; if increasing it more, it can cause seizure-->coma -In a coma, the brain does not have much activity ("brain dead") and many cannot wake up -Increases frequency of Cl- opening and too many Cl- influx.
48
Is it easy or hard to OD on benzodiazepines?
Hard; easy on barbiturates
49
Pharmacological properties of benzodiazepines
-Anxiolytic -Sleep Physiology -Reduce sleep latency -Increase total sleep time -Increase stage 2 -Decrease REM -Decrease stage 3 and 4 (good or bad?)--bad because you still feel like you did not get enough sleep -Tolerance and rebound to delta and REM -Anticonvulsant activity -Muscle relaxant -Cardiovascular and respiratory depression (major issue when combine with other agents) -Anterograde amnesia -Unable to recall events that occurred **Not as commonly used as sleeping agents as before **You increase total sleeping time, but decrease amount of time in REM
50
Toxicology of benzodiazepines
Side Effects (Dose dependent) -Sedation -Confusion -Ataxia -Daytime Sedation -With longer acting agents, tolerance develops -Weakness, Headache, Vertigo, Nausea, Paradoxical effects Precautions and Interactions -Other sedatives, Alcohol -Pregnancy and breast-feeding -Drug Dependence and Abuse -Abuse Potential -->Low vs barbiturates -Small “Kick” (Often when in combination with other drugs of abuse) **Does not lead to coma **Often OD from multiple agents **Alcohol also acts on GABA receptor, so pt can get pleasure from EtOH and BZD
51
BENZODIAZEPINE ANTAGONIST
Flumazenil (Romazicon®) -Therapeutic use-->treat BZD overdose Side Effects -Induce Convulsions* -Panic Attacks* -Agitation -Confusion -Nausea and Vomiting -Headache *are for those who developed dependence
52
Is flumazenil a barbituate antagonist?
NO
53
Non-Benzos (Z-Hypnotics): act as a BZD binding site
-BZ1 receptor
54
Examples of Z-hypnotics
Zolpidem (Ambien®, Ambien CRTM) Short-term treatment of insomnia With difficulty of sleep-onset Ambien CRTM for sleep maintenance Zaleplon (Sonata®) Short-term treatment of insomnia (7-10 days) Rapid acting, Rapidly eliminated Little tolerance or dependence Eszopiclone (LunestaTM) Active enantiomer of zopiclone 50 times greater affinity Treatment of insomnia Approved for long-term use **These have a very specific binding **Some take zolpidem (short term) version for longer time, but not great practice
55
Common features of Z-hypnotics -Metabolism -OD tx
Metabolism CYP3A4 to some extent Overdose Treatment Flumazenil (Romazicon®)
56
Z-hypnotics side effects
-Daytime drowsiness, dizziness, ataxia, nausea, and vomiting -Cause less negative effects on sleep patterns vs. BZD -Sleep-driving, sleep-cooking, sleep-eating, sleep-sex (FDA: warn your patient)
57
Illicit Use of Sedative-Hypnotics That Target the Benzodiazepine Binding Site
Benzodiazepines -Flunitrazepam (C-IV) ~Not Available in United States ~“Roofies” ~DEA recommends changing to C-I ~Anterograde Amnesia >Dangerous aid for sexual assault (mainly combine with alcohol) -Clonazepam (C-IV) (research use in treating social deficits of autism) Klonopin® Nonbenzodiazepines Zolpidem (C-IV) Ambien® and Ambien CRTM “A-minus” and “Zombie Pills” Dangerous aid for sexual assault Teen party drug
58
Barbiturates Long acting
Anticonvulsants -Phenobarbital (Luminal®) -Mephobarbital (Mebaral®)
59
Barbiturates short to intermediate acting
Sedative-Hypnotics -Amobarbital (Amytal®) -Butabarbital (Butisol Sodium®) -Pentobarbital (Nembutal®) -Secobarbital (Seconal®) -Aprobarbital (Alurate®)
60
Barbiturates ultra-short acting
IV Anesthetics -Thiopental (Pentothal®) -Methohexital (Brevital® Sodium) -Thiamylal (Surital®)
61
Pharmacology of barbiturates
-Anticonvulsant -Idiosyncratic excitement and pain -Dependence -Tolerance -Abuse -Withdrawal -Overdose -“After Effect” (Hangover, Accumulation) -Sleep Physiology -Comparable to BZD -Decrease REM -Slow Deep Sleep -Cardiovascular Depression (at high doses) -Respiratory Depression (death) -Enzyme Interactions -Compete for Cytochrome P450s for metabolism -Enzyme Induction
62
PK of barbiturates
Duration of Action -Inversely proportional to lipid solubility Decrease of Activities -Metabolic transformations and redistribution Ultra-Short and Short Acting -Determined by redistribution Anesthetics -Determined by lipid solubility and rapid redistribution Long Half-life -Accumulation
63
Summary of BZD and barbiturates
-Barbiturtates (BBT): bind to all GABAA a1-5; Increase the duration of channel opening; and direct effects on GABAA channel (high doses); higher risk -Benzodiazepines (BZDs): bind to all GABAA a1-5; Increase frequency of GABAA channel opening; medium risk -Z-Hypnotics: bind to GABAA BZ1 receptors of a1; Increase frequency of GABAA channel opening; lower risk -The use and limitation of Flumazenil **Flumazenil is used for BZD and Z-hypnotic OD **Flumazenil cannot be used for barbiturate OD -New GABA drugs are being tested to treat a variety of conditions and target different subunits. -Depression, autism (excitation/inhibition imbalance)-->ketamine is the most effective drug for depression -GABAA, GABAB